By Pepi Sappal •
Published: 23 Apr 2020 • 2:25
The study will analyse the efficiency and security of an anitiviral drug called Remdesivir to treat Covid-19 patients.
Costa del Sol’s Hospital Clinico de Malaga has announced that it is participating in a drug trial for coronavirus (Covid-19), with the University Hospital of Virgen de Sevilla.
THE study will analyse an anitiviral drug called Remdesivir to treat Covid-19 patients. According to the hospital, the trial will analyse the efficiency and safety of the drug on patients who have moderate and serious Covid-19 infections.
The trial forms part of a much larger international study, and involves at least 13 Spanish hospitals, including the Malaga’s Virgen de la Victoria University Hospital.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our
Share your story with us by emailing email@example.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
Download our media pack in either English or Spanish.